Implementation of Digital PCR in a Diagnostic Lab: Evaluation of Minimal Residual Disease
This webinar describes the implementation of a digital PCR system in an academic hospital setting to manage the treatment of cancer patients.
Benjamin Tournier, from the molecular pathology department of University Hospital Dijon, will share details of his lab's liquid biopsy setup, which is using the Naica 3-color Crystal Digital PCR system from Stilla Technologies to manage melanoma and lung cancer patients under targeted therapy.
Attendees of this webinar will:
- Gain a better understanding of the liquid biopsy process for metastatic melanoma and lung cancer patients
- Understand the Naica System workflow and its advantages
- Learn the benefits of digital PCR for the detection of circulating tumor DNA, circulating tumor cells, and circulating tumor exosomes in liquid biopsy
- Understand the advantages of digital PCR for monitoring patients and their treatment
Tuesday, September 25, 2018-11:00 am